Literature DB >> 6294189

Neuropeptides in the pathogenesis of obesity-associated benign acanthosis nigricans.

J E Bernstein, J Rothstein, K Soltani, L E Levine.   

Abstract

The association of acanthosis nigricans with pituitary tumors and insulin-resistant diabetes suggests that a pituitary peptide may promote papillomatosis and acanthosis characteristic of acanthosis nigricans. Although such a peptide has not been isolated, it may derive by sequential cleavage from the 31,000-dalton precursor peptide to ACTH and beta-lipotropin (beta-LPH). In order to evaluate the role of pituitary peptides in the pathogenesis of acanthosis nigricans, we compared plasma levels of beta-endorphin (beta-EP) and ACTH in plasma of 8 fasting patients with obesity-associated benign acanthosis nigricans and 7 fasting normal controls utilizing sensitive radioimmunoassay procedures. Mean plasma beta-EP levels for the acanthosis nigricans and control subjects were not significantly different (90 pg/ml vs. 140 pg/ml), nor was any significant difference observed between plasma ACTH levels of the 2 groups (42.3 and 31.2 pg/ml, respectively.) Our data indicate that plasma levels of the pituitary-derived peptides ACTH and beta-EP are not increased in obesity-associated benign acanthosis nigricans, and suggest that its proposed hormonal mediator might originate independently from the large peptide precursor of ACTH, beta-LPH and their fragments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6294189     DOI: 10.1111/1523-1747.ep12530848

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  2 in total

1.  Methodological aspects on immunohistochemistry in dermatology with special reference to neuronal markers.

Authors:  A Ljungberg; O Johansson
Journal:  Histochem J       Date:  1993-10

2.  Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American children.

Authors:  Juan C Lopez-Alvarenga; Geetha Chittoor; Solomon F D Paul; Sobha Puppala; Vidya S Farook; Sharon P Fowler; Roy G Resendez; Joselin Hernandez-Ruiz; Alvaro Diaz-Badillo; David Salazar; Doreen D Garza; Donna M Lehman; Srinivas Mummidi; Rector Arya; Christopher P Jenkinson; Jane L Lynch; Ralph A DeFronzo; John Blangero; Daniel E Hale; Ravindranath Duggirala
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.